Matches in Nanopublications for { ?s ?p "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP644695.RAjaEPGcRLOSPHsjuXc2bb2bH1fyWvFJLDF4AHHaDw9nU130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644695.RAjaEPGcRLOSPHsjuXc2bb2bH1fyWvFJLDF4AHHaDw9nU130_provenance.
- NP374492.RACPwL642sYGAafDGI85gFwwL1S0_34PRhK4PjZZj6WXY130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374492.RACPwL642sYGAafDGI85gFwwL1S0_34PRhK4PjZZj6WXY130_provenance.
- NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_provenance.
- NP1047603.RAbQOPuUm8-Sa7k7bQYePMBlvRYWMO4XQHtv9hMVBXx_E130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047603.RAbQOPuUm8-Sa7k7bQYePMBlvRYWMO4XQHtv9hMVBXx_E130_provenance.
- NP1047604.RAWweIPpRluTxeLRw-McCQII2cz4fhWukt5Cp3LlieJHs130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047604.RAWweIPpRluTxeLRw-McCQII2cz4fhWukt5Cp3LlieJHs130_provenance.
- NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_provenance.